During the past decade, Binzhou Medical University Hospital conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 2 clinical trials were completed, i.e. on average, 13.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 2 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Binzhou Medical University Hospital" #1 sponsor was "Shandong Provincial Hospital" with 3 trials, followed by "Takeda" with 3 trials sponsored, "Shandong University" with 2 trials sponsored, "Biogen" with 1 trials sponsored and "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Binzhou Medical University Hospital" #1 collaborator was "Binzhou Medical University" with 2 trials as a collaborator, "Central Hospital of Shengli Oilfield" with 2 trials as a collaborator, "Linyi People's Hospital" with 2 trials as a collaborator, "Zibo municipal hospital" with 2 trials as a collaborator and "Peking University Care Luzhong Hospital" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Binzhou Medical University Hospital" are "Advanced Endometrial Cancer" (1 trials), "Carotid Artery Diseases" (1 trials), "Colitis, Ulcerative" (1 trials), "Colonoscopy" (1 trials) and "Crohn Disease" (1 trials). Many other conditions were trialed in "Binzhou Medical University Hospital" in a lesser frequency.

Most popular intervention types in "Binzhou Medical University Hospital" are "Drug" (8 trials), "Other" (3 trials), "Device" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Dexlansoprazole" (2 trials), "Lansoprazole" (2 trials), "Acetyllevocarnitine Hydrochloride Tablets" (1 trials) and "Anlotinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Binzhou Medical University Hospital" are 14 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Binzhou Medical University Hospital". 3 are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Binzhou Medical University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Binzhou Medical University Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".